Navigation Links
Dendreon Expands Launch of PROVENGE
Date:3/10/2011

SEATTLE, March 10, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) announced today that the U.S. Food and Drug Administration (FDA) approved the remainder of its New Jersey manufacturing facility, allowing the company to significantly increase the availability of PROVENGE® (sipuleucel-T) to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  

Last April, upon receiving FDA approval of PROVENGE, Dendreon launched the world's first patient-specific prostate cancer immunotherapy from 12 workstations in its New Jersey facility.  With the FDA approval of 36 additional workstations, the New Jersey facility will now have a total of 48 approved workstations.  Dendreon will bring these new workstations online in a staged approach.  

PROVENGE is designed to induce an immune response against prostatic acid phosphatase (PAP), an antigen expressed in most prostate cancers, and is the first in a new therapeutic class of drugs known as autologous cellular immunotherapies.

"PROVENGE has the largest reported survival benefit in patients with asymptomatic or minimally symptomatic metastatic prostate cancer, with the most common side effects being primarily transient and mild to moderate. As such, PROVENGE is the standard of care for these patients," said Daniel George, M.D., director of GU Medical Oncology and the Prostate Clinic at Duke University Medical Center. "The increased availability of PROVENGE will allow more treatment centers and patients across the country to access this important treatment option."

In anticipation of the availability of the additional workstations, Dendreon expects to have approximately 225 infusion centers prepared to treat their first patient by the end of the second quarter, approximately 450 infusion centers upon en
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Exercise and Closing of Overallotment Option
2. Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016
3. Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
4. Dendreon Announces Presentation of PROVENGE Data at the American Society of Hematology and the Society of Urologic Oncology Annual Meetings
5. Dendreon Announces Webcast Presentation at Credit Suisse 2010 Health Care Conference
6. Dendreon Reports Third Quarter 2010 Financial Results
7. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
8. Dendreon Statement on CMS National Coverage Analysis
9. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
10. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
11. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The ... recombinant proteins, is placing renewed emphasis on alternate ... rise as a number of factors are converging ... pharmaceutical makers and their delivery device partners . ... refractory conditions, the growing trend toward self-administration for ...
(Date:5/17/2013)... -- Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) a ... patent-pending technologies poised to redefine how consumers receive energy, medicines, ... business update teleconference and webcast for shareholders and the investment ... PM ET. Fuse Science, Inc. CEO, ... will be joined by Rubin Hanan , ...
(Date:5/17/2013)... 17, 2013  PENTAX Medical, a healthcare industry ... global leader in ultrasound imaging, recently announced renewed ... enable further innovation in the development of Endoscopic ... systems and PENTAX Medical endoscopic portfolio have formed ... EUS systems. This agreement will continue to grow ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3
... of Hypertension,s Twenty-Third ... Annual Scientific Meeting - A cumulative forty-five percent ... of BENICAR(R) (olmesartan medoxomil), and BENICAR HCT(R) (olmesartan medoxomil/hydrochlorothiazide) achieved ... normotension (< 120/80 mm Hg) (placebo:1.4%)., - Eight out of 10 (cumulative ...
... Florida and Scripps Research in La ... ... and LA JOLLA, Calif., May 14 /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. ... Scripps Research,Institute, a non-profit biomedical research organization, today announced,that an agreement ...
Cached Medicine Technology:New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4
(Date:5/19/2013)... Today, Zane Benefits, Inc. published ... insurance . Zane Benefits, which provides comprehensive and ... is the leader in health care reform, ... . , According to Zane Benefits’ website, many ... the value of small business health insurance for ...
(Date:5/19/2013)... Corpus Christi, TX (PRWEB) May 19, 2013 ... home security systems companies. Homeowners who are considering ... options and services of the nation's leading security system ... security systems reviews the best DIY home security ... results. Every year 6Webs.com reviews dozens of home security ...
(Date:5/19/2013)... Fat Burning Furnace developed by Rob ... people with fat burning diet plans, training ... Burning Furnace package, people will receive the Fat Burning ... quickly. The Fat Burning Furnace manual includes fat loss ... muscle mass. In addition, this book covers step-by-step instructions, ...
(Date:5/19/2013)... Farming methods have changed many times ... 10,000 years ago. Most recently, the Green Revolution has ... genetically engineered seeds and by applying chemical fertilizers and ... these techniques due to the adverse environmental and health ... surge in interest in organic, sustainable farming practices and ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Vegas Hotel ... is proud to announce the launch it's all new ... the MGM Grand on 5/19/2013. Consumers traveling to Las ... special pricing available on VegasHotelEscapes.com's website. Travelers will be ... beat any competitors price. , Vegas Hotel Escapes specializes ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3
... were women who also received training to manage the ... may seem best at preventing illness rather than treating ... activity could make an immediate difference for people with ... chronic pain syndrome who exercised moderately for four months ...
... University of Virginia clinical psychologists has found that teens who ... to exhibit delinquent behavior in early adulthood than their peers ... study also suggests that early sex may play a role ... adulthood., The finding is published in the current online edition ...
... Terms, quarterly report analyzes the information, needs that drove ... ... third quarter, NEW YORK, Nov. 12 ... ongoing series of quarterly reports intended to shed light on,the most ...
... Company Brings Global U.N. Environmental Initiative to ... its,commitment to sustainability and social responsibility, today ... up their sleeves, grabbed their spades and ... company announced that it has joined the ...
... on Striking Nurses, BECKLEY, W.Va., Nov. 12 ... Health Care (ARH), represented by,the Kentucky and West ... to call public attention to the underhanded and,violent ... their strike,which began Oct. 1. ARH has escalated ...
... eDiets.com,Inc. (Nasdaq: DIET ), leveraging the power ... consumers and businesses, today announced that it,has rescheduled ... report results for its third quarter ended September ... Wednesday, November 14, 2007 and,will host a conference ...
Cached Medicine News:Health News:Exercise Eases Fibromyalgia Symptoms: Study 2Health News:Exercise Eases Fibromyalgia Symptoms: Study 3Health News:Early teen sex may not be a path to delinquency, study shows 2Health News:SearchMedica.com Reveals Top Searches Among Medical Professionals 2Health News:SearchMedica.com Reveals Top Searches Among Medical Professionals 3Health News:Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials 2Health News:Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials 3Health News:Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials 4Health News:Nurses Protest Violent Tactics Against Picketers 2Health News:eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call 2
Straight shafts with heavy Elschnig teeth. Flat serrated handle with slide style lock and polished finished....
Straight shafts with fine Pierse type tips. Flat smooth handle with dull finish....
Straight shafts with 1 x 2 Elsching style teeth. Wide serrated handle with polished finish....
Straight crisscross serrated tips. Flat handle with holes and polished finish....
Medicine Products: